Suppr超能文献

具有抗微管蛋白活性的多取代吡咯化合物的对接和亲水性评分

Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity.

作者信息

Tripathi Ashutosh, Fornabaio Micaela, Kellogg Glen E, Gupton John T, Gewirtz David A, Yeudall W Andrew, Vega Nina E, Mooberry Susan L

机构信息

Department of Medicinal Chemistry & Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA 23298-0540, USA.

出版信息

Bioorg Med Chem. 2008 Mar 1;16(5):2235-42. doi: 10.1016/j.bmc.2007.11.076. Epub 2007 Dec 4.

Abstract

Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of alphabeta-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r(2) of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses.

摘要

在微管蛋白的秋水仙碱结合位点结合的化合物已引起了相当大的关注,研究表明这些药物可抑制微管动力学并抑制微管蛋白聚合。本文报道了18种多取代吡咯化合物的数据,包括对人MDA-MB-435细胞的抗增殖活性以及将这些化合物对接至αβ-微管蛋白模型后计算得到的结合自由能。这些对接计算与HINT相互作用分析能够呈现抑制剂的复杂结构和结合模式,使得计算得到的结合自由能与测量值相关,相关系数r²为0.76。结合口袋的结构分析确定了介导结合的重要分子间接触。如实验所见,与JG-03-14(3,5-二溴-4-(3,4-二甲氧基苯基)-1H-吡咯-2-羧酸乙酯)形成的复合物最为稳定。这些结果阐明了结合过程,并且在设计新的基于吡咯的秋水仙碱位点抑制剂方面应具有价值,因为这些化合物的合成非常容易实现。

相似文献

1
Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity.
Bioorg Med Chem. 2008 Mar 1;16(5):2235-42. doi: 10.1016/j.bmc.2007.11.076. Epub 2007 Dec 4.
2
Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities are Predicted for C-2 Analogs in the Colchicine Site.
ACS Med Chem Lett. 2012 Jan 12;3(1):53-57. doi: 10.1021/ml200217u. Epub 2011 Nov 1.
3
Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrrole.
Mol Pharmacol. 2007 Jul;72(1):132-40. doi: 10.1124/mol.107.034876. Epub 2007 Apr 24.
4
Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.
Mol Pharmacol. 2016 Feb;89(2):287-96. doi: 10.1124/mol.115.101592. Epub 2015 Dec 11.
6
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents.
Eur J Med Chem. 2021 Mar 15;214:113229. doi: 10.1016/j.ejmech.2021.113229. Epub 2021 Jan 29.

引用本文的文献

1
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile.
Bioorg Chem. 2024 Jul;148:107489. doi: 10.1016/j.bioorg.2024.107489. Epub 2024 May 22.
2
Synthesis and Anticancer Activity of Mitotic-Specific 3,4-Dihydropyridine-2(1)-thiones.
Int J Mol Sci. 2021 Feb 28;22(5):2462. doi: 10.3390/ijms22052462.
5
Hydrazonoyl Chlorides as Precursors for Synthesis of Novel Bis-Pyrrole Derivatives.
Molecules. 2016 Mar 9;21(3):326. doi: 10.3390/molecules21030326.
6
Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.
Mol Pharmacol. 2016 Feb;89(2):287-96. doi: 10.1124/mol.115.101592. Epub 2015 Dec 11.

本文引用的文献

2
Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrrole.
Mol Pharmacol. 2007 Jul;72(1):132-40. doi: 10.1124/mol.107.034876. Epub 2007 Apr 24.
3
Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents.
Nat Prod Rep. 2007 Apr;24(2):327-57. doi: 10.1039/b515619j. Epub 2007 Mar 8.
4
The consequences of scoring docked ligand conformations using free energy correlations.
Eur J Med Chem. 2007 Jul;42(7):921-33. doi: 10.1016/j.ejmech.2006.12.037. Epub 2007 Jan 21.
5
2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
J Med Chem. 2006 Oct 19;49(21):6412-5. doi: 10.1021/jm060616k.
7
Novel combretastatin analogues endowed with antitumor activity.
J Med Chem. 2006 Jun 1;49(11):3143-52. doi: 10.1021/jm0510732.
10
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.
Nature. 2004 Mar 11;428(6979):198-202. doi: 10.1038/nature02393.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验